Bertis and Innoquest Diagnostics have entered into a strategic partnership to bring Bertis’ technology to the Southeast Asian market.
Bertis and Innoquest Diagnostics have entered into a strategic partnership to bring Bertis’ technology to the Southeast Asian market. On July 3, Bertis, a company specializing in proteomics-based precision medicine technology, led by CEOs Dong-young Noh and Seung-man Han, announced the signing of a strategic partnership agreement with Innoquest Diagnostics, the leading clinical diagnostics laboratory in Singapore. …